pharmaceutical industry

Drug companies are sponsoring creation of a new medical disorder known as female sexual dysfunction in order to build markets for drugs among women, despite controversy surrounding the medicalisation of sexual problems, finds an article in this week’s British Medical Journal. Over the past six years, researchers with close ties to the pharmaceutical industry have been developing and defining the new disorder at company sponsored meetings, writes journalist Ray Moynihan.